A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer
Clinical trial NCT07621159 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07621159
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2027-11-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.